Clinical Trials Logo

Primary PCI clinical trials

View clinical trials related to Primary PCI.

Filter by:
  • None
  • Page 1

NCT ID: NCT05605288 Recruiting - Clinical trials for Coronary Artery Disease

Distal Versus Conventional Transradial Artery Access for Coronary Catheterization in Patients With STEMI

DR-STEMI
Start date: May 23, 2024
Phase: N/A
Study type: Interventional

Recently, a novel distal transradial, through anatomical snuffbox, approach has been proposed for undertaking percutaneous coronary angiography and interventions. The existing literature has evaluated distal transradial access (dTRA) as a feasible and safe approach, with faster hemostasis, lower rates of periprocedural complications and reduced incidence of radial artery occlusion (RAO). Aim of the present study is to compare dTRA versus conventional TRA access in patients with STEMI undergoing coronary angiography and interventions regarding peri- and post-procedural characteristics.

NCT ID: NCT05329155 Active, not recruiting - STEMI Clinical Trials

Early Administration of Heparin at FMC for PPCI of STEMI Patients

HELP-PPCI
Start date: July 20, 2022
Phase: N/A
Study type: Interventional

Heparin is the first choice of anticoagulation drug for primary PCI of STEMI patients. However, the priority of use of hepairn in first medical contact or in Cathlab has not yet studied. Previous study revealed early use of antithrombotic drugs could improve patient's survival. Here we supposed that use of heparin at first medical contact could increase the TIMI flow 3 grade ratio in STEMI patients and improve patient's survival and/or reduce MACE rather than in Cathlab.

NCT ID: NCT04221919 Not yet recruiting - Primary PCI Clinical Trials

Different β -Blockers in STEMI and Primary PCI

Start date: January 2020
Phase: N/A
Study type: Interventional

Carvedilol, target dose: 50 mg daily; Bisoprolol, target dose: 10 mg daily; Metoprolol tartrate, target dose: 150 mg daily; Metroprolol succinate, target dose: 200 mg daily

NCT ID: NCT04034940 Recruiting - Oxidative Stress Clinical Trials

Correlations Between Oxidative Stress Biomarkers, h-FABP and Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Undergoing Primary PCI

OxiSTEMIhFABP
Start date: August 2019
Phase: N/A
Study type: Interventional

The investigators intend to evaluate Oxidative Stress biomarkers through a. Catalase Activity Assay; b. Lipid Peroxidation Assay; c. SOD Assay; d. Total Antioxidant Capacity Assay; e. Glutathione Peroxidase at patients with acute myocardial infarction STEMI referred for primary PCI; The investigators also aim to evaluate cardiac necrosis by measuring Heart Fatty Acid Binding Protein (H-FABP), TnI, CK, CK-MB, LDH and AST in these patients with acute myocardial infarction referred for primary PCI; Also, the investigators intend to evaluate body composition through bioimpedance spectroscopy (BCM - Fresenius Care) at the moment of admission. The investigators aim to fully characterise these patients through oxidative millieu, hFABP and make correlations with LVEF dysfunction.

NCT ID: NCT03526367 Withdrawn - Clinical trials for ST Elevation Myocardial Infarction

A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI

TRACK-AMI
Start date: February 20, 2019
Phase: Phase 4
Study type: Interventional

The CIAKI,as the third complication of PCI, was associated with adverse cardiac events after procedure. Moreover, because the rate of periprocedure hydration is inadequate in STEMI patients before primary PCI, the incidence of CIAKI is higher significantly in these patients. The cardiovascular pleiotropic effects of statins in addition to lipid have been widely concerned. The previous studies demonstrated usage of statin in periprocedure could decrease the risk of CIAKI. Compared with hydration, the usage of statin to prevention CIAKI show the advantages in clinical practice, for example,there is no need to consider the cardiac function.The optimal strategies for preventting CIAKI in STEMI patients undergoing primary PCI needed further studies to explore. What's more, whether a synergistic effect of hydration and statin or not is unknown.

NCT ID: NCT01136837 Completed - Primary PCI Clinical Trials

The Prognostic Significance of a Fragmented QRS Complex After Primary Percutaneous Coronary Intervention

Start date: November 2008
Phase: N/A
Study type: Observational

To investigate the prognostic significance of a fragmented QRS (fQRS) complex in a patient who had undergone primary percutaneous coronary intervention (PCI).